Entering text into the input field will update the search result below

Alnylam Pharma is said to be a potential target for Novartis - Bloomberg

Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • Alnylam Pharmaceuticals (NASDAQ:ALNY) may be a potential target for Novartis (NYSE:NVS) as investor push for the drugmaker to make an acquisition and use its cash. Alnylam rose 4.2% in premarket trading.
  • Alnylam, with a market cap of more

Recommended For You

About ALNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ALNY--
Alnylam Pharmaceuticals, Inc.